Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,398,750
+$802,250 QoQ
Shares Held
75,000
+50.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#96
of 216 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Checkpoint Capital L.P. holds $389,759,659 across 6 Biotechnology names. TRVI ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,186,000 | $131,681,580 | |
| 2 | ARGX |
Argenx SE
|
131,283 | $121,800,428 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
410,353 | $76,850,909 | |
| 4 | CYTK |
Cytokinetics Inc
|
475,000 | $40,465,250 | |
| 5 | IRON |
Disc Medicine, Inc.
|
240,125 | $17,562,742 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
This page
|
75,000 | $1,398,750 |
All Filings in TRVI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,398,750 | 75,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $596,500 | 50,000 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $4,466,636 | 1,084,135 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $835,000 | 250,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,490,265 | 500,089 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,745,982 | 506,082 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,731,703 | 1,292,316 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||